Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

Research out today is the latest to suggest that semaglutide can significantly lower people's risk of dementia.

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower blood ...

A blockbuster diabetes and weight-loss drug might be doing more than controlling blood sugar—it could also be protecting the ...

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

The study, carried out by experts from the University of Nottingham and funded by the National Institute for Health Research ...

Over a hundred new drugs which could halt dementia are being developed at the “start of a journey to a cure”, scientists say. Experts have heralded the findings from a global review of drugs ...

New research suggests that dementia prevention should begin much earlier than previously thought—possibly as early as ...